New partnership Analis & GeneMind to offer Next-Generation Sequencer (NGS) in Benelux

GeneMind: One Platform, One Provider for End-to-End Next Gen Sequencing (NGS) Sequencing without compromise | Photo: ANALIS

Analis is thrilled to unveil an exciting new partnership with GeneMind Biosciences Co., Ltd. for the Benelux market.

GeneMind Biosciences is a fast-growing global Next-Generation Sequencer (NGS) manufacturer, providing a complete sequencing ecosystem including scalable sequencing platforms, automation-friendly workflows, reagents, consumables, and integrated bioinformatic pipelines.

This new collaboration expands Analis’s portfolio, enabling seamless integration and complete workflows from nucleic acid extraction and library preparation to sequencing, bioinformatic analysis, and reporting, all supported by a single trusted partner.

Applications:

• Oncology and precision medicine
• Whole-genome and whole-exome sequencing (WGS & WES)
• Infectious disease and microbiology
• Single-cell & spatial transcriptomics
• Reproductive health and NIPT

Key benefits:

• Clinical and research applications
• Complete workflow, no third-party dependency
• Faster turnaround time (TAT) without compromising accuracy
• Cost-effective scalable sequencing
• Lifelong service & support

More information on our website.

GeneMind: One Platform, One Provider for End-to-End NGS Sequencing without Compromise

Written by

ANALIS

Distributor & manufacturer of instruments and furniture for laboratories. More than a label of trust, YOUR QUALITY LABEL Read more